A randomized comparison of once- versus twice-daily Mmx® mesalamine for the maintenance of remission in mild-to-moderate ulcerative colitis

被引：0
|
作者：
Kamm, Michael A.
Colombel, Jean-frederic
Kornbluth, Asher
Diebold, Ron
Barrett, Karen
Karlstadt, Robyn G.
Joseph, Raymond E.
机构：
来源：
GASTROENTEROLOGY | 2007年 / 132卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A510 / A510
页数：1
相关论文
共 50 条
  • [31] Once daily MMX mesalazine for the treatment of mild-to-moderate ulcerative colitis: a phase II, dose-ranging study
    D'Haens, G.
    Hommes, D.
    Engels, L.
    Baert, F.
    Van der Waaij, L.
    Connor, P.
    Ramage, J.
    Dewit, O.
    Palmen, M.
    Stephenson, D.
    Joseph, R.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 24 (07) : 1087 - 1097
  • [32] MMX mesalamine for the treatment of active mild-to-moderate ulcerative colitis: An evidence-based medicine analysis
    Sandborn, William J.
    Lichtenstein, Gary R.
    Kamm, Michael A.
    Barrett, Karen
    Joseph, Raymond E.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S431 - S432
  • [33] Long-term remission rates in patients with mild-to-moderate ulcerative colitis who require an MMX™ mesalamine dose increase to induce initial remission
    Hanauer, Stephen B.
    Kamm, Michael A.
    Diebold, Ron
    Barrett, Karen
    Joseph, Raymond E.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S462 - S462
  • [34] Once- Versus Twice-Daily Tacrolimus Are the Formulations Truly Equivalent?
    Barraclough, Katherine A.
    Isbel, Nicole M.
    Johnson, David W.
    Campbell, Scott B.
    Staatz, Christine E.
    DRUGS, 2011, 71 (12) : 1561 - 1577
  • [35] MMX® Mesalamine 2.4g/Day Maintains Clinical Remission in Patients With Mild-to-Moderate Ulcerative Colitis, Irrespective of Prior Treatment
    Kane, Sunanda V.
    Solomon, Don M.
    Palmen, Mary
    Barrett, Karen
    GASTROENTEROLOGY, 2010, 138 (05) : S700 - S700
  • [36] ONCE- VERSUS TWICE-DAILY FEEDING OF MILK REPLACER TO CALVES
    WILLETT, LB
    ALBRIGHT, JL
    CUNNINGHAM, MD
    JOURNAL OF DAIRY SCIENCE, 1969, 52 (03) : 390 - +
  • [37] Once-Versus Twice-daily Mesalazine to Induce Remission in Paediatric Ulcerative Colitis: A Randomised Controlled Trial
    Turner, Dan
    Yerushalmi, Baruch
    Kori, Michal
    Broide, Efrat
    Mozer-Glassberg, Yael
    Shaoul, Ron
    Kolho, Kaija-Leena
    Shteyer, Eyal
    Shamaly, Hussein
    Ledder, Oren
    Cohen, Shlomi
    Peleg, Sarit
    On, Avi
    Levine, Arie
    JOURNAL OF CROHNS & COLITIS, 2017, 11 (05): : 527 - 533
  • [38] The PODIUM Trial of Once-Daily Versus Twice-Daily Mesalazine Dosing in Ulcerative Colitis: Maintenance of Mucosal Healing
    Dignass, Axel U.
    Muls, Vinciane
    Silvennoinen, Jouni
    Pool, Marco Oudkerk
    Befrits, Ragnar
    Broberg, Per
    Lukas, Milan
    GASTROENTEROLOGY, 2010, 138 (05) : S520 - S520
  • [39] The PODIUM trial of once-daily versus twice-daily mesalazine dosing in ulcerative colitis: maintenance of mucosal healing
    Lukas, Milan
    Muls, Vinciane
    Silvennoinen, Jouni
    Pool, Oudkerk Marco
    Befrits, Ragnar
    Broberg, Per
    Dignass, Axel
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2010, 45 : 74 - 74
  • [40] Induction of mucosal healing in mild-to-moderate ulcerative colitis in patients treated with MMX⊙ mesalamine: established versus newly diagnosed disease
    Lichtenstein, G.
    Sandborn, W.
    Kamm, M.
    Solomon, D.
    Karlstadt, R.
    Barrett, K.
    Abhyankar, B.
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (12) : S35 - S35
12345